Nephrostomy Devices Market
Number of pages: 100 | Report Format: PDF | Published date: May 31, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 1.26 billion |
|
Revenue Forecast in 2031 |
US$ 2.43 billion |
|
CAGR |
7.6% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global nephrostomy devices market was valued at US$ 1.26 billion in 2022 and is expected to register a revenue CAGR of 7.6% to reach US$ 2.43 billion by 2031.
Nephrostomy Devices Market Fundamentals
Nephrostomy devices are used in urology to provide a temporary or permanent alternative pathway for urine drainage when the normal flow of urine from the kidneys to the bladder is obstructed. These devices are typically used in cases where the urinary tract is blocked, damaged, or infected, preventing the normal passage of urine. A nephrostomy is a procedure in which a small incision is made in the skin of the patient's back, and a catheter is inserted into the kidney through the incision. The catheter is then connected to a drainage bag or system, allowing urine to bypass the obstruction and be drained externally. Nephrostomy devices consist of several Products, including anchoring devices, external drainage systems, catheters, and dressing.
Nephrostomy devices may be used temporarily until the underlying cause of the urinary obstruction can be treated, or they may be used as a long-term solution when the block cannot be completely resolved. The duration of nephrostomy depends on the patient's condition and the underlying cause of the urinary obstruction.
Nephrostomy Devices Market Dynamics
Urinary tract obstructions, such as kidney stones, tumors, or strictures, are common conditions that can lead to the need for nephrostomy procedures. The rising prevalence of these conditions is the primary driver for the growth of the global nephrostomy devices market. According to the American Cancer Society’s estimation, for 2021, the U.S. is estimated to have 82,290 new cases of bladder cancer and 17,710 deaths due to it. Improvements in healthcare facilities, especially in developing regions, contribute to the growth of the nephrostomy devices market. Enhanced healthcare infrastructure enables better access to nephrostomy procedures and devices, boosting the market growth. Additionally, there is a growing awareness among healthcare professionals and patients about urinary tract obstructions and the availability of nephrostomy procedures. This awareness leads to early diagnosis and intervention, fueling the demand for the nephrostomy devices market.
However, nephrostomy procedures are not without risks and potential complications. These can include infection, bleeding, damage to surrounding structures, and catheter dislodgement. Complications can deter patients and healthcare providers from opting for nephrostomy procedures, limiting the demand for nephrostomy devices. In some cases, alternative treatment options for urinary tract obstructions, such as minimally invasive procedures, endoscopic techniques, or surgical interventions, may be available. The availability of these alternatives can reduce the demand for nephrostomy procedures and devices, impacting market growth. Additionally, alternative treatment options, complications and risks, and cost constraints are some of the restraints impeding the overall market growth.
Nephrostomy Devices Market Ecosystem
The global nephrostomy devices market is analyzed from three perspectives: product, end user, and region.
Nephrostomy Devices Market by Product
Based on the product, the global nephrostomy devices market is segmented into drainage tubes, guidewires, sheath dilators, nephrostomy catheters, and others.
The guidewires segment dominated the market with the principal revenue share in 2022, attributed to the product's less invasive nature. Guidewires are a specific type of medical device used during nephrostomy procedures. Guidewires are thin, flexible wires with tapered tips inserted into the urinary tract to provide guidance and facilitate the placement of other devices, such as catheters, during the procedure. Guidewires play a crucial role in nephrostomy procedures by navigating through the urinary tract, including the kidney, ureter, and bladder, to reach the desired location for catheter insertion. They help ensure precise and accurate placement of the nephrostomy catheter, minimizing the risk of complications and optimizing the procedure’s success. Nephrostomy guidewires are typically made of stainless steel or nitinol, which are known for their flexibility, durability, and compatibility with medical procedures. These aspects contribute to the growth of the guidewires segment.
The drainage tubes segment also accounted for a prominent revenue market. Drainage tubes are used to drain urine in patients undergoing nephrostomy procedures. These tubes are inserted into the kidney through the nephrostomy catheter to provide a pathway for urine to bypass any obstructions and be collected externally. Drainage tubes are designed to facilitate efficient and continuous urine drainage from the kidney. They are typically made of biocompatible materials such as silicone or polyurethane, which are compatible with the urinary system and minimize the risk of tissue irritation or reaction. Drainage tubes come in various sizes and configurations to accommodate patient anatomies and specific procedural requirements. The size and diameter of the drainage tube may vary depending on factors such as the patient's age, body size, and the nature of the urinary obstruction being treated. These factors promote the growth of the drainage tube segment.
Nephrostomy Devices Market by End User
Based on the end user, the global nephrostomy devices market is segmented into hospitals, ambulatory surgery centers, and others.
The ambulatory surgical centers (ASCs)segment is expected to register the fastest growth with a CAGR of 8.1% during the forecast period because they provide more personalized services. ASCs are specialized healthcare facilities where nephrostomy procedures are performed on an outpatient basis. ASCs are designed to provide surgical and interventional procedures that do not require overnight hospitalization, offering a convenient and cost-effective alternative to traditional hospital settings. ASCs are outpatient facilities where patients undergo surgical procedures and are discharged on the same day without needing overnight hospital stays. Nephrostomy procedures can be performed in ASCs, allowing patients to receive the necessary treatment in a more convenient and less resource-intensive environment. These overall factors contribute to the growth of the ambulatory surgical centers segment.
The hospitals segment dominated the market with the maximum revenue share in 2022, owing to rising kidney-related disorders. For instance, according to the Center for Disease Control and Prevention Factsheet of July 2022, in the U.S., more than 37 million individuals suffer from chronic kidney disorders. Hospitals are healthcare facilities that provide comprehensive medical services, including surgical procedures like nephrostomy, to both inpatients and outpatients. Hospitals have specialized departments and units dedicated to surgical interventions, including nephrostomy procedures. Inpatients who require closer monitoring, intensive care, or longer hospital stays due to their medical condition may undergo nephrostomy procedures in this setting. Hospitals are equipped with state-of-the-art surgical infrastructure, including operating rooms, imaging facilities (such as X-ray, ultrasound, or fluoroscopy), and recovery areas. These facilities allow for efficient and safe performance of nephrostomy procedures, ensuring optimal patient outcomes. These overall factors contribute to the growth of the hospitals segment.
Nephrostomy Devices Market by Region
Geographically, the global nephrostomy devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global nephrostomy devices market with the largest revenue share in 2022 with a revenue CAGR of 7.45%, attributed to increased product awareness, beneficial reimbursement regulations, access to highly qualified physicians, the existence of well-established healthcare institutions, and rising prevalence of kidney related disorders. For instance, according to the National Kidney Foundation report, the prevalence rate in the United States climbed from 3.8% in the late 1970s to 8.8% in the late 2000s and reached 10% in 2013-2014. Additionally, companies across the region are continuously involved in partnerships, mergers, and acquisitions, which are also expected to improve the nephrostomy devices market outlook.
Nephrostomy Devices Market Competitive Landscape
The prominent players operating in the global nephrostomy devices market are:
Nephrostomy Devices Market Strategic Developments
Nephrostomy devices are used in the field of urology to provide a temporary or permanent alternative pathway for urine drainage when the normal flow of urine from the kidneys to the bladder is obstructed.
The global nephrostomy devices market was valued at US$ 1,261.7 million in 2022.
The estimated market size of the global nephrostomy devices market in 2031 is US$ 2,439.3 million.
The revenue CAGR of the nephrostomy devices market during the forecast period will be 7.60% from 2023 to 2031.
Some prominent players operating in the global nephrostomy devices market areB. Braun SE, Argon Medical, Angiodynamics Inc., Envaste Limited, Cook Group Incorporated, and Coloplast Group
*Insights on financial performance are subject to the availability of information in the public domain